Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET

Company Participants

Matthew Calistri - Vice President, Corporate Strategy and Investor Relations

Tony Coles - Chairperson and Chief Executive Officer

Raymond Sanchez - Chief Medical Officer

John Renger - Chief Scientific Officer

Mark Bodenrader - Interim Chief Financial Officer

Conference Call Participants

Paul Matteis - Stifel

Joseph Thome - TD Cowen

Michael Yee - Jefferies

Jessica Fye - JP Morgan

Graig Suvannavejh - Mizuho Securities

Omari Baruti - Goldman Sachs

Douglas Tsao - H.C. Wainwright

Elaine Kim - Cantor Fitzgerald

Operator

Good morning and welcome to Cerevel Therapeutics First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please note that this call may be recorded.

I will now hand the call over to Matt Calistri, Vice President of Investor Relations.

Matthew Calistri

Thank you. Good morning, everyone. We appreciate you joining us for our first quarter 2023 earnings call. On today's call, you'll be hearing from Dr. Tony Coles, our Chairperson and Chief Executive Officer; Dr. Ray Sanchez, our Chief Medical Officer; Dr. John Renger, our Chief Scientific Officer; and Mark Bodenrader, our Interim Chief Financial Officer.

During our call today, please refer to our press release from this morning, detailing our first quarter 2023 performance, as well as our updated corporate presentation, both of which are available on our website. I would like to remind you that we will be making forward-looking statements that reflect our current views related to, among other things, the potential attributes and benefits of our product candidates and the format and timing of our product development activities and clinical trials. We strongly encourage you to review the information that we file with the SEC regarding specific risks and uncertainties.

I will now hand the call over to Dr. Tony Coles, Chairperson and CEO of Cerevel to provide an overview of our achievements and outlook.

Tony Coles

Good morning and thank you, Matt. Thank you for joining us for our first quarter 2023 business results call.

This morning we announced the appointment of Ron Renaud as the next President and CEO of Cerevel, and I am really looking forward to partnering with him as I return to where my career with Cerevel began in 2018 and that's Chairperson on the Board. I have known Ron for more than a decade and his tremendous experience and leadership will serve the organization well as it prepares for an exciting future, most notably the seven data readouts that we expect in the coming year.